A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
暂无分享,去创建一个
G. Bauman | S. Pautler | A. Louie | G. Rodrigues | B. Ahmad | A. Warner | M. Mackenzie | R. Correa | Craig Johnson